Skip to main content
. 2020 Oct 9;61(12):8. doi: 10.1167/iovs.61.12.8

Figure 2.

Figure 2.

The experimental protocol. White arrows indicate extravascular administration and solid arrows intravascular administration of vasoactive compounds that were followed by diameter recordings represented by the horizontal lines. Large arrows: Addition of the ATP agonist. Small arrows: Addition of compounds for establishing the reference diameters using U46619 (preconstriction), KPSS (viability and maximal constriction) and papaverine (maximal dilatation).